212 related articles for article (PubMed ID: 15111803)
1. Aberrant bony vasculature associated with activating fibroblast growth factor receptor mutations accompanying Crouzon syndrome.
Tholpady SS; Abdelaal MM; Dufresne CR; Gampper TJ; Lin KY; Jane JA; Morgan RF; Ogle RC
J Craniofac Surg; 2004 May; 15(3):431-5; discussion 436-8. PubMed ID: 15111803
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of
Lee KKL; Peskett E; Quinn CM; Aiello R; Adeeva L; Moulding DA; Stanier P; Pauws E
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266836
[TBL] [Abstract][Full Text] [Related]
3. Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.
Liu J; Nam HK; Wang E; Hatch NE
Calcif Tissue Int; 2013 May; 92(5):451-66. PubMed ID: 23358860
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific responses to aberrant FGF signaling in complex head phenotypes.
Martínez-Abadías N; Motch SM; Pankratz TL; Wang Y; Aldridge K; Jabs EW; Richtsmeier JT
Dev Dyn; 2013 Jan; 242(1):80-94. PubMed ID: 23172727
[TBL] [Abstract][Full Text] [Related]
5. Minor Suture Fusion in Syndromic Craniosynostosis.
Runyan CM; Xu M D W; Alperovich M; Massie M D JP; Paek G; Cohen BA; Staffenberg DA; Flores RL; Taylor JA
Plast Reconstr Surg; 2017 Sep; 140(3):434e-445e. PubMed ID: 28574949
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic diversity in patients with craniosynostoses unrelated to Apert syndrome: the role of fibroblast growth factor receptor gene mutations.
Ito S; Sekido K; Kanno H; Sato H; Tanaka M; Yamaguchi K; Yamamoto I
J Neurosurg; 2005 Jan; 102(1 Suppl):23-30. PubMed ID: 16206730
[TBL] [Abstract][Full Text] [Related]
7. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability.
Park WJ; Meyers GA; Li X; Theda C; Day D; Orlow SJ; Jones MC; Jabs EW
Hum Mol Genet; 1995 Jul; 4(7):1229-33. PubMed ID: 8528214
[TBL] [Abstract][Full Text] [Related]
8. Jackson-Weiss syndrome: identification of two novel FGFR2 missense mutations shared with Crouzon and Pfeiffer craniosynostotic disorders.
Tartaglia M; Di Rocco C; Lajeunie E; Valeri S; Velardi F; Battaglia PA
Hum Genet; 1997 Nov; 101(1):47-50. PubMed ID: 9385368
[TBL] [Abstract][Full Text] [Related]
9. A model for the pharmacological treatment of crouzon syndrome.
Perlyn CA; Morriss-Kay G; Darvann T; Tenenbaum M; Ornitz DM
Neurosurgery; 2006 Jul; 59(1):210-5; discussion 210-5. PubMed ID: 16823318
[TBL] [Abstract][Full Text] [Related]
10. The craniofacial phenotype of the Crouzon mouse: analysis of a model for syndromic craniosynostosis using three-dimensional MicroCT.
Perlyn CA; DeLeon VB; Babbs C; Govier D; Burell L; Darvann T; Kreiborg S; Morriss-Kay G
Cleft Palate Craniofac J; 2006 Nov; 43(6):740-8. PubMed ID: 17105336
[TBL] [Abstract][Full Text] [Related]
11. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.
Jabs EW; Li X; Scott AF; Meyers G; Chen W; Eccles M; Mao JI; Charnas LR; Jackson CE; Jaye M
Nat Genet; 1994 Nov; 8(3):275-9. PubMed ID: 7874170
[TBL] [Abstract][Full Text] [Related]
12. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
Ignelzi MA; Wang W; Young AT
J Bone Miner Res; 2003 Apr; 18(4):751-9. PubMed ID: 12674336
[TBL] [Abstract][Full Text] [Related]
14. [On the effect of mutations of the fibroblast growth factor receptors as exemplified by three cases of craniosynostoses].
Preising MN; Schindler S; Friedrich M; Wagener H; Golan I; Lorenz B
Klin Monbl Augenheilkd; 2003 Oct; 220(10):669-81. PubMed ID: 14577033
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor signaling in cranial suture development and pathogenesis.
Hajihosseini MK
Front Oral Biol; 2008; 12():160-177. PubMed ID: 18391500
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of craniosynostosis-derived fibroblasts.
Carinci F; Bodo M; Tosi L; Francioso F; Evangelisti R; Pezzetti F; Scapoli L; Martinelli M; Baroni T; Stabellini G; Carinci P; Bellucci C; Lilli C; Volinia S
Mol Med; 2002 Oct; 8(10):638-44. PubMed ID: 12477974
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms in calvarial bone and suture development, and their relation to craniosynostosis.
Rice DP; Rice R; Thesleff I
Eur J Orthod; 2003 Apr; 25(2):139-48. PubMed ID: 12737212
[TBL] [Abstract][Full Text] [Related]
18. Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model.
Shen K; Krakora SM; Cunningham M; Singh M; Wang X; Hu FZ; Post JC; Ehrlich GD
Orthod Craniofac Res; 2009 Aug; 12(3):254-62. PubMed ID: 19627528
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.
Eswarakumar VP; Ozcan F; Lew ED; Bae JH; Tomé F; Booth CJ; Adams DJ; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18603-8. PubMed ID: 17132737
[TBL] [Abstract][Full Text] [Related]
20. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes.
Rutland P; Pulleyn LJ; Reardon W; Baraitser M; Hayward R; Jones B; Malcolm S; Winter RM; Oldridge M; Slaney SF
Nat Genet; 1995 Feb; 9(2):173-6. PubMed ID: 7719345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
